DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8zrh58/allergies) has announced the addition of the "Allergies - Pipeline Review, H2 2013" report to their offering.
Global Markets Direct's, 'Allergies - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Allergies, complete with latest updates, and special features on late-stage and discontinued projects. Allergies - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Allergies.
- A review of the Allergies products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Allergies pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Companies Mentioned:
- ALK-Abello A/S
- ANERGIS SA
- Actelion Ltd
- ActogeniX NV
- Antigen Express, Inc.
- AstraZeneca PLC
- BioLineRx, Ltd.
- Biomay AG
- Biotec Pharmacon ASA
- Clarassance, Inc.
- Cytos Biotechnology AG
- Dainippon Sumitomo Pharma Co., Ltd.
- EpiVax, Inc.
- GlaxoSmithKline plc
- Idera Pharmaceuticals, Inc.
- Immune Design Inc.
- ImmunoFrontier, Inc.
- Immupharma Plc
- Indus Biotech Private Limited
- IntelGenx Technologies Corp.
- Interprotein Corporation
- Japan Tobacco Inc.
- Monosol Rx, LLC
- NAL Pharmaceuticals Ltd.
- Novartis AG
- Proteo, Inc.
- RaQualia Pharma Inc.
- SIFI S.p.A
- Shionogi & Co., Ltd.
- SuppreMol GmbH
- ToleroTech Inc.
- United Biomedical, Inc.
- Vaxine Pty Ltd
- Viromed Co., Ltd.
- Xencor, Inc.
For more information visit http://www.researchandmarkets.com/research/8zrh58/allergies
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
